GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DuChemBio Co Ltd (XKRX:176750) » Definitions » Beneish M-Score

DuChemBio Co (XKRX:176750) Beneish M-Score : -2.90 (As of May. 13, 2024)


View and export this data going back to 2014. Start your Free Trial

What is DuChemBio Co Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.9 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for DuChemBio Co's Beneish M-Score or its related term are showing as below:

XKRX:176750' s Beneish M-Score Range Over the Past 10 Years
Min: -4.49   Med: -3.5   Max: 4.81
Current: -2.9

During the past 8 years, the highest Beneish M-Score of DuChemBio Co was 4.81. The lowest was -4.49. And the median was -3.50.


DuChemBio Co Beneish M-Score Historical Data

The historical data trend for DuChemBio Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DuChemBio Co Beneish M-Score Chart

DuChemBio Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial -4.10 -4.31 4.81 -2.21 -2.90

DuChemBio Co Semi-Annual Data
Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score Get a 7-Day Free Trial -4.10 -4.31 4.81 -2.21 -2.90

Competitive Comparison of DuChemBio Co's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, DuChemBio Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DuChemBio Co's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, DuChemBio Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where DuChemBio Co's Beneish M-Score falls into.



DuChemBio Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of DuChemBio Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9592+0.528 * 0.789+0.404 * 1.0114+0.892 * 1.0701+0.115 * 1.1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.8625+4.679 * -0.090109-0.327 * 0.8552
=-2.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was ₩9,103 Mil.
Revenue was ₩34,695 Mil.
Gross Profit was ₩11,797 Mil.
Total Current Assets was ₩12,668 Mil.
Total Assets was ₩49,277 Mil.
Property, Plant and Equipment(Net PPE) was ₩16,186 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩5,760 Mil.
Selling, General, & Admin. Expense(SGA) was ₩1,730 Mil.
Total Current Liabilities was ₩19,357 Mil.
Long-Term Debt & Capital Lease Obligation was ₩7,030 Mil.
Net Income was ₩4,001 Mil.
Gross Profit was ₩0 Mil.
Cash Flow from Operations was ₩8,441 Mil.
Total Receivables was ₩8,868 Mil.
Revenue was ₩32,422 Mil.
Gross Profit was ₩8,699 Mil.
Total Current Assets was ₩12,331 Mil.
Total Assets was ₩51,351 Mil.
Property, Plant and Equipment(Net PPE) was ₩17,978 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩7,297 Mil.
Selling, General, & Admin. Expense(SGA) was ₩1,875 Mil.
Total Current Liabilities was ₩24,187 Mil.
Long-Term Debt & Capital Lease Obligation was ₩7,965 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(9102.815 / 34695.49) / (8867.805 / 32422.307)
=0.262363 / 0.273509
=0.9592

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(8698.599 / 32422.307) / (11797.149 / 34695.49)
=0.268291 / 0.34002
=0.789

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (12668.141 + 16185.586) / 49276.827) / (1 - (12331.354 + 17977.619) / 51351.399)
=0.414456 / 0.409773
=1.0114

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=34695.49 / 32422.307
=1.0701

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(7296.948 / (7296.948 + 17977.619)) / (5759.927 / (5759.927 + 16185.586))
=0.288707 / 0.262465
=1.1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(1730.257 / 34695.49) / (1874.566 / 32422.307)
=0.04987 / 0.057817
=0.8625

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((7029.692 + 19357.391) / 49276.827) / ((7964.687 + 24187.452) / 51351.399)
=0.535487 / 0.62612
=0.8552

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(4000.507 - 0 - 8440.782) / 49276.827
=-0.090109

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

DuChemBio Co has a M-score of -2.90 suggests that the company is unlikely to be a manipulator.


DuChemBio Co Beneish M-Score Related Terms

Thank you for viewing the detailed overview of DuChemBio Co's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


DuChemBio Co (XKRX:176750) Business Description

Traded in Other Exchanges
N/A
Address
Daegu 47, Jinyang Building, 4th floor, Chungjeong-ro 2, Gyeonggi, Seoul, KOR, 190-3
DuChemBio Co Ltd is engaged in manufacturing and sale of radiopharmaceuticals and radioactive medicines. It also imports and sells medical equipment related to nuclear medicines.

DuChemBio Co (XKRX:176750) Headlines

No Headlines